Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Parasitic Diseases Therapeutics Market: By Product: Antiprotozoal Therapeutics, Anthelminthic Therapeutics, Scabicides And Pediculicides Therapeutics; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments

Global Parasitic Diseases Therapeutics Market Outlook

The global parasitic diseases therapeutics market is expected to grow in the forecast period of 2022-2027 at a CAGR of about 5.2%. The market is primarily being driven by the rising initiatives and programs to eliminate parasitic diseases.

 

Global Parasitic Diseases Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Segmentation

Amebiasis, African sleeping disease, trichomoniasis, giardiasis, trypanosomiasis, leishmaniasis, and malaria are all parasitic diseases that need treatment. Based on the product, the parasitic diseases therapeutics market can be divided into:

 

Global Parasitic Diseases Therapeutics Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Antiprotozoal Therapeutics
  • Anthelminthic Therapeutics
  • Scabicides And Pediculicides Therapeutics

The EMR report looks into the regional parasitic diseases therapeutics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Parasitic Diseases Therapeutics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Protozoal, along with helminthic worm diseases, have raised the mortality and morbidity of prophylactic therapy. Preventive chemotherapy is used to monitor the spread within a population of helminthic infections. The high prevalence of malaria worldwide prompted researchers to develop different vaccines to prevent the disease from spreading. Researchers are also developing a variety of prophylactic vaccines to treat and prevent skin leishmaniasis and visceral leishmaniasis. The growing acceptance of these prophylactic vaccines for the prevention and control of parasite diseases is one of the key market developments on parasitic diseases, which would have a positive effect on the market growth.

The occurrence of protozoan, helminth, as well as ectoparasite infections, is rapidly rising. The number of individuals infected with whipworms and hookworms is increasing annually. The number of cases of African trypanosomiasis recorded has also increased considerably, particularly in countries in sub-Saharan Africa like Zambia, Tanzania, Uganda, and Malawi. Likewise, in parts of Central America, South America, and Mexico, the prevalence of Chagas disease is high. In addition, the prevalence of schistosomiasis is also rising globally. The increasing prevalence of these parasites will lead to a growing demand for the treatment of parasites. The antiprotozoal therapeutics segment accounted for the largest market share in 2020.

However, the challenges related to the discovery of antiparasitic drugs and disease diagnosis, increased drug resistance, lack of effective therapies, and side-effects may impede the development of the parasite diseases therapeutics industry in the coming years.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global parasitic diseases therapeutics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Bayer AG 
  • F. Hoffmann-La Roche Ltd. 
  • GlaxoSmithKline Plc 
  • Pfizer Inc. (NYSE: PFE)
  • Sanaria Inc.
  • Others

The EMR report gives an in-depth insight into the parasitic diseases therapeutics market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region
Breakup by Product Antiprotozoal Therapeutics, Anthelminthic Therapeutics, Scabicides And Pediculicides Therapeutics
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Bayer AG (ETR: BAYN), F. Hoffmann-La Roche Ltd. (SWX: ROG), GlaxoSmithKline Plc (LON: GSK), Pfizer Inc. (NYSE: PFE), Sanaria Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface  
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Parasitic Diseases Therapeutics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Parasitic Diseases Therapeutics Historical Market (2017-2021) 
    8.3    Global Parasitic Diseases Therapeutics Market Forecast (2022-2027)
    8.4    Global Parasitic Diseases Therapeutics Market by Product
        8.4.1    Antiprotozoal Therapeutics
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Antithelminthic Therapeutics
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Scabicides and Pediculicides Therapeutics
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Global Parasitic Diseases Therapeutics Market by Region
        8.5.1    Market Share
            8.5.1.1    North America
            8.5.1.2    Europe
            8.5.1.3    Asia Pacific
            8.5.1.4    Latin America
            8.5.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure  
    12.2    Company Profiles
        12.2.1    Bayer AG
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    F. Hoffmann-La Roche Ltd.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    GlaxoSmithKline plc
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Pfizer Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Sanaria Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications 
        12.2.6    Others
13    Industry Events and Developments


List of Key Figures and Tables

1.    Global Parasitic Diseases Therapeutics Market: Key Industry Highlights, 2017 and 2027
2.    Global Parasitic Diseases Therapeutics Historical Market: Breakup by Product (USD Billion), 2017-2021
3.    Global Parasitic Diseases Therapeutics Market Forecast: Breakup by Product (USD Billion), 2022-2027
4.    Global Parasitic Diseases Therapeutics Historical Market: Breakup by Region (USD Billion), 2017-2021
5.    Global Parasitic Diseases Therapeutics Market Forecast: Breakup by Region (USD Billion), 2022-2027
6.    North America Parasitic Diseases Therapeutics Historical Market: Breakup by Country (USD Billion), 2017-2021
7.    North America Parasitic Diseases Therapeutics Market Forecast: Breakup by Country (USD Billion), 2022-2027
8.    Europe Parasitic Diseases Therapeutics Historical Market: Breakup by Country (USD Billion), 2017-2021
9.    Europe Parasitic Diseases Therapeutics Market Forecast: Breakup by Country (USD Billion), 2022-2027
10.    Asia Pacific Parasitic Diseases Therapeutics Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    Asia Pacific Parasitic Diseases Therapeutics Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Latin America Parasitic Diseases Therapeutics Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Latin America Parasitic Diseases Therapeutics Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Middle East and Africa Parasitic Diseases Therapeutics Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Middle East and Africa Parasitic Diseases Therapeutics Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Global Parasitic Diseases Therapeutics Market Structure

Key Questions Answered in the Report

The global parasitic diseases therapeutics market is projected to grow at a CAGR of nearly 5.2% in the forecast period of 2022-2027.

The major drivers of the industry include rising disposable incomes, increasing population, and the rising prevalence of parasites.

The rising initiatives and programmes to eliminate parasitic diseases is expected to be a key trend guiding the growth of the industry.

North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market.

The major products of parasitic diseases therapeutics in the industry are antiprotozoal therapeutics, anthelminthic therapeutics, and scabicides and pediculicides therapeutics.

The leading players in the market are Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Pfizer Inc., and Sanaria Inc., among others.

Analyst Review

The global parasitic diseases therapeutics market is being driven by the rising prevalence of parasites. Aided by the rising initiatives and programmes to eliminate parasitic diseases, the industry is expected to witness a healthy growth in the forecast period of 2022-2027, growing at a CAGR of 5.2%.

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on product, the market can be segmented into antiprotozoal therapeutics, anthelminthic therapeutics, and scabicides and pediculicides therapeutics. The major regional markets for parasitic diseases therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above industry include Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Pfizer Inc., and Sanaria Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER